References
1. Borisova A.V., Kozachenko A.V., Frankevich V.E., Chagovets V.V., Kononikhin A.S., Starodubtseva N.L., Kogan E.A., Adamyan L.V. Risk factors for recurrence of external genital endometriosis after surgery: a prospective cohort study. Meditsinskiy sovet [Medical Advice]. 2018; 7: 32-8. (in Russian)
2. Arabipoor A. Oxidative stress statues in serum and follicular fluid of women with endometriosis. Cell J. 2017; 18 (4): 582-7.
3. Brown J., Farquhar C. An overview of treatments for endometriosis. JAMA. 2015; 313 (3): 296-7.
4. Adamyan L.V., Serov V.N., Andreeva E.N., Baranov I.I., Dubrovina S.O., Kozachenko A.V., KuleshovV.M., Podzolkova N.M., Prilepskaya V.N., Radzinsky V.E., Sonova M.M., Tikhomirov A.L., Uvarova E, V., Chernukha G.E., Shikh E.V., Yarmolinskaya M.I. Resolution of the expert meeting on the topic “Possibilities of personalization of endometriosis hormone therapy using dydrogesterone. Problemy reproduktsii [Russian Journal of Human Reproduction]. 2018; 24 (5): 41-4. (in Russian)
5. Nakagawa K., Hisano M., Sugiyama R., Yamaguchi K. Measurement of oxidative stress in the follicular fluid of infertility patients with an endometrioma. Arch. Gynecol. Obstet. 2016. 293 (1): 197-202.
6. Gabitova D.M, Ryzhikova V.O., Ryzhikova M.A. Antioxidant defense system of the body. Bashkirskiy khimicheskiy zhurnal [Bashkir Chemical Journal]. 2006; 13 (2): 94-6. (in Russian)
7. Saridogan E. Adolescent endometriosis. Eur J Obstet Gynecol Reprod Biol. 2017; 209: 46-9.
8. Zakirova Ya.R., Babaeva E.I., Orazov M.R., Aryutin D.G. Comprehensive assessment of the reproductive health of patients with external genital endometriosis after surgical treatment. Human. Sport. Medicine. 2016; 16 (4): 32-42. (in Russian)
9. Denny E., Weckesser A., Jones G., Bibila S., Daniels J., Bhattacharya S.; PREEMPT team. Women’s experiences of medical treatment for endometriosis and its impact on PRE-EMPT trial participation: a qualitative study. Pilot Feasibility Stud. 2018; 4: 168.
10. Isidor B. Familial deep endometriosis: A rare monogenic disease? Eur J Ob-stet Gynecol Reprod. Biol. 2018; 221: 190-3.
11. Gasparyan S.A., Cheprasova G.P., Burgova E.H. Assessment of the antioxidant defense of the body in genital endometriosis. In: Cytomorphometry in medicine and biology: fundamental and applied aspects. Mоscow, 2009: 103. (in Russian)
12. Fu J., Song H., Zhou M., Zhu H., Wang Y., Chen H., Huang W. Progesterone receptor modulators for endometriosis. Cochrane Database Syst. Rev. 2017; 7.
13. Gibson D.A., Simitsidellis I., Collins F., Saunders P.T.K. Endometrial intracri-nology: oestrogens, androgens and endometrial disorders. Int J Mol Sci. 2018; 19 (10).
14. Hwang H., Chung Y. J., Lee S. R., Park H. T., Song J. Y., Kim H., et al. Clinical evaluation and management of endometriosis: guideline for Korean patients from Korean Society of Endometriosis. Obstet Gynecol Sci. 2018; 61 (5): 55-64.
15. Pechenikova V.A., Akopyan R.A. Evolution of views on the etiopathogenesis of internal and external genital endometriosis. Vestnik Rossiyskoy voyenno-meditsin-skoy akademii [Bulletin of the Russian Military Medical Academy]. 2018; 2: 234-9. (in Russian)
16. Lethaby A., Puscasiu L., Vollenhoven B. Preoperative medical therapy before surgery for uterine fibroids. Cochrane Database Syst. Rev. 2017; 11: CD000547.
17. Orazov M.R. Controversial issues of endometriosis. Akusherstvo i ginekologiya: novosti, mneniya, obuchenie [Obstetrics and Gynecology: News, Opinions, Training]. 2016; 3: 72-84. (in Russian)
18. Nasiri N., Moini A., Eftekhari-Yazdi P. et al. Oxidative stress statues in serum and follicular fluid of women with endometriosis. Cell J. 2017; 18 (4): 582-7.
19. Piepenbrink A., Failing K., Riesenbeck A., Schmid P., Hoffmann B. Downregu-lation of LH in the bitch after application of the GnRH-agonist buserelin as a slow-release implant. Tierarztl. Prax. Ausg. K Kleintiere Heimtiere. 2017; 45 (3): 147-52.
20. Zheng W., Cao L., Xu Z., Ma Y., Liang X. Anti-angiogenic alternative and complementary medicines for the treatment of endometriosis: a review of potential molecular mechanisms. Evid. Based Complement. Alternat. Med. 2018; 2018: 4128984.
21. Vercellini P., Buggio L., Berlanda N., Barbara G., Somigliana E., Bosari S. Es-trogen-progestins and progestins for the management of endometriosis. Fertil. Steril. 2016; 106 (7): 15520-71.
22. Santali P., Tran C., Gayet V., Bourdon M., Maignien C., Marcellin L., et al. Oligo-anovulation is not a rarer feature in women with documented endometriosis. Fertil. Steril. 2018; 110 (5): 941-8.
23. De Sanctis V., Matalliotakis M., Soliman A., Elsefdy H., Di Maio S., Fiscina B. A focus on the distinctions and current evidence of endometriosis in adolescents. Best Pract. Res. Clin. Obstet. Gynaecol. 2018; 15: 138-50.